Characterization of SARS-CoV-2 Spike mutations important for infection of mice and escape from human immune sera
Raveen Rathnasinghe(Seqirus (United States)), Michael Schotsaert(Icahn School of Medicine at Mount Sinai), Carles Martínez‐Romero(Icahn School of Medicine at Mount Sinai), Jana De Vrieze(Ghent University), Ashley-Beathrese T. Salimbangon(Icahn School of Medicine at Mount Sinai), Sadaf Aslam(Icahn School of Medicine at Mount Sinai), Lily Eaker(Icahn School of Medicine at Mount Sinai), Denise Jurczyszak(Icahn School of Medicine at Mount Sinai), Thomas Kehrer(Icahn School of Medicine at Mount Sinai), Shelcie Fabre, Virginia Gillespie(Icahn School of Medicine at Mount Sinai), David A. Meekins(Kansas State University), Emily D. Ferreri(Icahn School of Medicine at Mount Sinai), Kayla T. Russo(Icahn School of Medicine at Mount Sinai), Miti Saksena(Icahn School of Medicine at Mount Sinai), Bruno G. De Geest(Ghent University), Stephen T. Yeung(Cornell University), Angela Choi(Moderna Therapeutics (United States)), Katherine F. Beach(Icahn School of Medicine at Mount Sinai), Daniel Stadlbauer(Icahn School of Medicine at Mount Sinai), Charles Gleason(Icahn School of Medicine at Mount Sinai), Komal Srivastava(Icahn School of Medicine at Mount Sinai), Rachel Chernet(SUNY Upstate Medical University), Sonia Jangra(Icahn School of Medicine at Mount Sinai), Giulio Kleiner(Icahn School of Medicine at Mount Sinai), Hala Alshammary(Icahn School of Medicine at Mount Sinai), Wanni A. Mendez(Icahn School of Medicine at Mount Sinai), Luis Martínez‐Sobrido(Texas Biomedical Research Institute), Levy A. Sominsky(Icahn School of Medicine at Mount Sinai), Florian Krammer(Icahn School of Medicine at Mount Sinai), Lisa Miorin(Columbia University Irving Medical Center), Ignacio Mena(Icahn School of Medicine at Mount Sinai), Chester D. McDowell(Kansas State University), Velmurugan Balaraman(Kansas State University), Angela A. Amoako(Icahn School of Medicine at Mount Sinai), Mahmoud Awawda(Icahn School of Medicine at Mount Sinai), Jüergen A. Richt(Kansas State University), Gagandeep Singh(Icahn School of Medicine at Mount Sinai), Soner Yildiz(Icahn School of Medicine at Mount Sinai), Lubbertus C. F. Mulder(Icahn School of Medicine at Mount Sinai), Anastasija Čupić(Icahn School of Medicine at Mount Sinai), Viviana Simon(Icahn School of Medicine at Mount Sinai), Chengjin Ye(Texas Biomedical Research Institute), Michael J. Corley(Cornell University), Adolfo Garcı́a-Sastre(Icahn School of Medicine at Mount Sinai), Amber S. Shin(Icahn School of Medicine at Mount Sinai), Maria C. Bermúdez‐González(Icahn School of Medicine at Mount Sinai)
Cited by 41
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Advances in the development of influenza virus vaccines
|Nature Reviews Drug Discovery|2015|597